1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for GLP-1 Receptor Agonist Exposure and Survival Outcomes in Newly Diagnosed Multiple Myeloma Treated With Daratumumab-Based Quadruplet Therapy: A Target Trial Emulation

MM - 626

GLP-1 Receptor Agonist Exposure and Survival Outcomes in Newly Diagnosed Multiple Myeloma Treated With Daratumumab-Based Quadruplet Therapy: A Target Trial Emulation

Colton Jones

Poster Presenter: Colton Jones

Thumbnail for GLP-1 Receptor Agonists and Major Clinical Outcomes in Adults With Classic Myeloproliferative Neoplasms and Type 2 Diabetes and/or Obesity: A Global Propensity Score-Matched Analysis

MPN - 1144

GLP-1 Receptor Agonists and Major Clinical Outcomes in Adults With Classic Myeloproliferative Neoplasms and Type 2 Diabetes and/or Obesity: A Global Propensity Score-Matched Analysis

Muluken Megiso

Poster Presenter: Muluken Megiso

Thumbnail for GLP-1 Receptor Agonists and Organ Function Outcomes in Amyloid Light-Chain Amyloidosis: A Real-World Analysis From the TriNetX Global Collaborative Network

MM - 1350

GLP-1 Receptor Agonists and Organ Function Outcomes in Amyloid Light-Chain Amyloidosis: A Real-World Analysis From the TriNetX Global Collaborative Network

Dhriti Sood

Poster Presenter: Dhriti Sood

Thumbnail for GLP-1 Receptor Agonists and SGLT2 Inhibitors in Multiple Myeloma and Plasma Cell Disorders: Protective, Harmful, or Both? A Scoping Review

MM - 852

GLP-1 Receptor Agonists and SGLT2 Inhibitors in Multiple Myeloma and Plasma Cell Disorders: Protective, Harmful, or Both? A Scoping Review

Yagnapriya Chirrareddy

Poster Presenter: Yagnapriya Chirrareddy

MM - 1086

GLP-1 Receptor Agonists and Venous Thromboembolism Risk in Multiple Myeloma

Priyanshi Maurya

Poster Presenter: Priyanshi Maurya

Thumbnail for GLP-1 RECEPTOR AGONISTS ARE ASSOCIATED WITH SIGNIFICANTLY REDUCED ALL-CAUSE MORTALITY, HOSPITALIZATION, AND SEPSIS IN PATIENTS WITH MULTIPLE MYELOMA AND TYPE 2 DIABETES: A PROPENSITY-MATCHED ANALYSIS OF THE TRINETX GLOBAL COLLABORATIVE NETWORK.

MM - 837

GLP-1 RECEPTOR AGONISTS ARE ASSOCIATED WITH SIGNIFICANTLY REDUCED ALL-CAUSE MORTALITY, HOSPITALIZATION, AND SEPSIS IN PATIENTS WITH MULTIPLE MYELOMA AND TYPE 2 DIABETES: A PROPENSITY-MATCHED ANALYSIS OF THE TRINETX GLOBAL COLLABORATIVE NETWORK.

Mevlut Ozmen

Poster Presenter: Mevlut Ozmen

Thumbnail for Golcadomide-A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy

ABCL - 142

Golcadomide-A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy

Muhamad Alhaj Moustafa

Poster Presenter: Muhamad Alhaj Moustafa

$Thumbnail for Golcadomide, a Potential First-in-Class, Oral Celmod ± Rituximab in the Phase 1/2 CC-99282-NHL-001 Study: Long-Term Follow-Up Results of Patients With Relapsed/Refractory Follicular Lymphoma$

IBCL - 141

Golcadomide, a Potential First-in-Class, Oral Celmod ± Rituximab in the Phase 1/2 CC-99282-NHL-001 Study: Long-Term Follow-Up Results of Patients With Relapsed/Refractory Follicular Lymphoma

Javier Munoz

Poster Presenter: Javier Munoz

$Thumbnail for GPRC5D-Targeted Therapies in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Single-Arm Meta-Analysis$

MM - 704

GPRC5D-Targeted Therapies in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Single-Arm Meta-Analysis

Basil Joy

Poster Presenter: Basil Joy